Alacip

Asociación Latinoamericana de Ciencia Política

  • HOME
  • INSTITUCIONAL
    • ALACIP
    • Comité Ejecutivo-Histórico
    • SECRETARÍA GENERAL
    • Convênios
      • ABCP
      • AMECIP
      • APSA
      • IPSA
  • CONGRESOS
    • CONGRESOS LATINOAMERICANOS DE CIENCIA POLÍTICA
      • 13º Congreso, Buenos Aires 2026
      • 12º Congreso, Lisboa 2024
      • 11º Congreso, Santiago de Chile 2022
      • 10º Congreso, Monterrey 2019
      • 9º Congreso, Montevideo 2017
      • 8º Congreso, Lima 2015
      • 7º Congreso, Bogotá 2013
      • 6º Congreso, Quito 2012
      • 5º Congreso, Buenos Aires 2010
      • 4º Congreso, San José de Costa Rica 2008
      • 3º Congreso, Campinhas 2006
      • 2º Congreso, Ciudad de México, 2004
      • 1º Congreso, Salamanca 2002
    • PREMIO TRAYECTORIA ACADÉMICA
      • Resultado III Premio (2026)
      • RESULTADO II PREMIO (2024)
        • CONVOCATORIA II PREMIO (2024)
      • RESULTADO I PREMIO (2022)
        • CONVOCATORIA I PREMIO (2022)
    • PONENCIAS
      • Congreso 2013
      • Congreso 2015
      • Congreso 2017
      • Congreso 2019
      • Congreso 2022
      • Congreso 2024
    • CONCURSO DE TESIS
      • Convocatoria XI Premio O’Donnell
      • Histórico de ganadores/as
  • MEMBRESÍA
    • Cómo asociarse
    • Ingresa a la página de miembros con tu usuario
  • GRUPOS DE INVESTIGACIÓN
    • Grupos de Investigación de ALACIP
    • CREACIÓN, GESTIÓN Y PARTICIPACIÓN
  • PUBLICACIONES
    • Publicaciones de la editorial ALACIP
    • Publicaciones de los Grupos de Investigación ALACIP
    • Publicaciones de nuestros miembros
    • Convocatorias: publicación de artículos académicos
  • NOTICIAS
    • Informativo Alacip
    • Noticias de los Grupos de Investigación
    • BOLETÍN ALACIP
      • Biblioteca
      • Becas, Premios, Cursos y Cargos docentes
      • Convocatoria para la publicación de artículos académicos y publicaciones de miembros ALACIP
      • Seminarios, Congresos y Conferencias
      • Libros
    • Café Virtual ALACIP
    • Charlas Metodologicas
    • Escuela Alacip
    • Noticias Generales
      • Programas y Seminarios
  • CONTACTO
Usted está aquí: Inicio / public / Coronavirus disease 2019

Coronavirus disease 2019

8 de agosto de 2026 by Brian

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Compartir esta página

Publicado en: public

Alacip en las redes sociales

Sobre ALACIP

La Asociación Latinoamericana de Ciencia Política (ALACIP) es una organización científica internacional sin fines de lucro, integrada por académicos, investigadores y profesionales, destinada a … Leer Más

Archivos

Política de Privacidad Alacip




Scroll Up